| |
|
|
|
KemPharm- Inc.
|
|
3.80 -0.05 (-1.30%) |
10/23/2017 3:59pm |
|
Open: |
3.78 |
Pre close: |
3.85 |
Target:
|
4.61
|
|
High: |
3.80 |
Low: |
3.75 |
Resistance:
|
3.95
4.20
|
|
Volume: |
15,396 |
Market Cap: |
55.70M |
Support:
|
3.54
2.95
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.80
|
MACD |
MACD(12,26):
|
0.08  |
|
MA(20): |
3.83 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
3.50 |
Stochastic Oscillator |
%K(14,3):
|
26.32 |
|
MA(250): |
3.75  |
%D(3): |
29.14 |
|
Average Volume(K) |
3-Month: |
6108
|
52-Week |
High:
|
5.40 |
|
10-Days: |
1788 |
Low: |
2.45 |
|
RSI |
RSI(14):
|
52.96 |
Change(%): |
8.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.100 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-2.720 |
Return on Assets (ttm) |
-24.4 |
Shares Float (M) |
8.39 |
|
EPS Est. Next Year |
-2.300 |
PEG Ratio |
0.00 |
% Held by Insiders |
37.41 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
41.42 |
|
Forward EPS |
-2.298 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
492 |
|
Book Value (p.s.) |
-2.680 |
EBITDA (p.s.) |
-2.289 |
P/E |
-1.23 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.42 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.63 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-16.76 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
